#stem cell multiple sclerosis

[stemcelltreatmenteurope-blog]

Clinical news for Multiple Sclerosis treatment with stem cells in United Kingdom

Multiple Sclerosis news in stem cell treatment comings from patients in the United Kingdom.  Patient with SPMS receives two stem cell treatments (from bone marrow and adipose tissue).  Treatment procedure lasted for two weeks after second procedure symptoms of Ms disease condition are generally improved.

Patient from the UK with Ms  

UK patient with Multiple Sclerosis 2nd check-up

Patient Leslie from the United Kingdom which Ms is diagnosed in 2007 several months after stem cell treatment feels significant improvements in his overall health condition. Multiple Sclerosis treatment was one in the end of 2015.

https://medium.com/@mstreatment/multiple-sclerosis-news-from-united-kingdom-13ab78cf8cf3#.ip9s894t6

[stemcelltreatmenteurope-blog]

Multiple Sclerosis Treatment Center

Multiple Sclerosis Treatment center is Swiss Medica branch clinic specialized in  ms treatment in Europe. ]

Ms treatment with stem cells

[stemcelltreatmenteurope-blog]

MS patient from United Kingdom feels 80% better after stem cell treatment

After published post in Whitchurch Herald magazine about ms patient from the United Kingdom 3 months after stem cell therapy, a patient feels 80% better and their multiple sclerosis symptoms significantly decreased. Also thanks to treatment with stem cells patient starts with the gym, he exercising in the gym 3 times a week. 

Ms treatment clinic visits patient at his home town, and make a short interview.

[stemcelltreatmenteurope-blog]

Patient with Multiple Sclerosis from United Kingdom

New Multiple Sclerosis treatment with stem cell therapy, shows very good result in treatment and bringing good news for all people who suffering from MS disease.  MS patient from UK, was visit Swiss Medica clinic in January, and after four months she feels improvement of her MS condition. 

New video about stem cell treatment for Multiple Sclerosis

This ms story from UK brings very encouraging news on the field of MS treatments.